Key facts
- Notable investors include Santé Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for ARI Therapeutics
- ·The full record, as it builds
Funding rounds
No funding rounds for ARI Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ARI Therapeutics
Developer of pharmaceutical products designed to address respiratory diseases through innovative drug research and development. The company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Ownership
- Privately Held (backing)
ARI Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ARI Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ARI Therapeutics in its N-PORT filings yet. We sweep new filings monthly.